ID   TYUC-1
AC   CVCL_4W84
DR   JCRB; JCRB1512
DR   Wikidata; Q54973487
RX   DOI=10.1158/1538-7445.AM2015-5126;
RX   PubMed=25667451;
RX   PubMed=29765522;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (DOI=10.1158/1538-7445.AM2015-5126).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1512
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6762; Esophageal small cell carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
RX   DOI=10.1158/1538-7445.AM2015-5126;
RA   Shimada Y., Okumura T., Takei Y., Watanabe K., Hirasawa A.,
RA   Yamane A., Nishiyama M., Nagata T., Tsukada K., Shimizu K.;
RT   "Establishment of an esophageal small cell carcinoma cell line
RT   (TYUC-1).";
RL   Cancer Res. 75 Suppl. 15:5126-5126(2015).
//
RX   PubMed=25667451;
RA   Okumura T., Shimada Y., Omura T., Hirano K., Nagata T., Tsukada K.;
RT   "MicroRNA profiles to predict postoperative prognosis in patients with
RT   small cell carcinoma of the esophagus.";
RL   Anticancer Res. 35:719-727(2015).
//
RX   PubMed=29765522; DOI=10.18632/oncotarget.24930; PMCID=PMC5940407;
RA   Ohmoto A., Suzuki M., Takai E., Rokutan H., Fujiwara Y., Morizane C.,
RA   Yanagihara K., Shibata T., Yachida S.;
RT   "Establishment of preclinical chemotherapy models for
RT   gastroenteropancreatic neuroendocrine carcinoma.";
RL   Oncotarget 9:21086-21099(2018).
//